Zoll Hospital Wearable Defibrillator Receives Premarket Approval from the FDA

Massachusetts–based Zoll Medical has been granted premarket approval by the FDA to market its wearable defibrillator.

The device is designed to continuously protect patients at risk of ventricular tachycardia or ventricular fibrillation during their stay in the hospital.

The unit is designed to deliver treatment within 60 seconds. — Cynthia Jessup